[Nalidixic acid].
D001419:Bacteria / Q000187:drug effects; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D009268:Nalidixic Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D009268:Nalidixic Acid
Nalidixinsyre.